Data from Pharmawand - Curated by EPG Health - Date added 13 June 2018

Aclaris Therapeutics announced the publication of the two pivotal trials leading to the FDA approval of Eskata (hydrogen peroxide) topical solution, 40% (w/w), for the treatment of raised seborrheic keratoses (SKs) in a prestigious peer-reviewed dermatology journal, the online Journal of the American Academy of Dermatology ahead of print. The article summarized the pivotal results demonstrating the safety and efficacy of ESKATA in treating raised seborrheic keratoses after one to two treatments.

The results show that at day 106, significantly more patients treated with 40% hydrogen peroxide topical solution (HP40) versus alternative treatment achieved Physician’s Lesion Assessment (PLA) scale (0:Clear; 1:Near-Clear; 2:up to 1mm thick, and 3:more than 1mm thick) PLA=0 on all 4 SKs (Study 1: 4% vs 0%; Study 2: 8% vs 0%, P<0.01 both) and 3 of 4 SKs (Study 1: 13% vs 0%; Study 2: 23% vs 0%; P<.0001 both). A higher mean per-patient percentage of SKs were Clear (Study 1: 25% vs 2%; Study 2: 34% vs 1%) and Clear/Near-Clear (Study 1: 47% vs 10%; Study 2: 54% vs 5%) with HP40 versus VEH. Local skin reactions were largely mild and resolved by day 106.

See: “Safety and efficacy of hydrogen peroxide topical solution, 40% (w/w) in patients with seborrheic keratoses: results from two identical, randomized, double-blind, placebo-controlled, Phase III studies (A-101-SEBK-301/302),” Baumann LS et al. Journal of the American Academy of Dermatology (2018; published online June 1, 2018), doi: 10.1016/j.jaad.2018.05.044.

Comments

You will need to login, to leave a comment.

epgonline.org is not monitored for collection of adverse event reports. Any adverse events should be reported to your national reporting agency and/or the manufacturer.

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Atopic Dermatitis

Atopic Dermatitis

The Atopic Dermatitis Knowledge Centre is an educational resource, intended for healthcare professionals, that provides credible medical information on the epidemiology, pathophysiology and burden of atopic dermatitis, as well as diagnostic techniques, treatment regimens and guideline recommendations.

Chronic Spontaneous Urticaria (CSU)

Chronic Spontaneous Urticaria (CSU)

Use our patient case studies to discover how experts diagnose and treat chronic spontaneous urticaria.

+ 7 more

Psoriasis

Psoriasis

See information on psoriasis pathophysiology, signs and symptoms, comorbidities, treatment options, and more.

+ 2 more

Load more

Related Content